Answer:
There is more than one kind of white blood cell
Explanation:
there is more than one type of white blood cells, for example Neutrophils normal percentage 40 to 60%, Lymphocytes 20 to 40%, and Monocytes 2 to 8%
Answer:
The client has to drink 1,350 mL between 7 a.m. and 10 p.m.
Explanation:
The answer requires a bit of problem solving analysis.
The client has to receive 1,800 mL in one day (24 hours).
<em>Between 7 a.m. and 10 p.m., he needs to receive 3/4 of the fluid. </em>This means that you have to calculate the amount of fluid by considering the given factors.
So, 3/4 of 1,800 mL is equivalent to 1,350 mL.<em> You can get this by multiplying 3/4 (0.75) to 1,800 and this will give you an answer of 1,350.</em>
Thus, the amount that the client will drink between 7 a.m. and 10 a.m. is 1,350 mL and the remaining 450 mL (1,800 mL minus 1,350 mL) will be consumed within the remaining time period of 21 hours.
Restlessness would indicate a possible toxic effect related to Oxybutynin chloride medication.
<h3>What Oxybutynin is used for?</h3>
- A medication called oxybutynin is used to treat the symptoms of an overactive bladder.
- These include the sudden, pressing desire to urinate (urinary urgency) having more frequent urination (urinary frequency).
<h3>What are the effects of Oxybutynin toxicity?</h3>
- Oxybutynin toxicity (overdose) causes central nervous system excitation, which includes jitteriness, restlessness, hallucinations, and irritability.
- Hypotension or hypertension, tachycardia, disorientation, a flushed or red face, and indications of respiratory depression are further symptoms of poisoning.
- The drug's common adverse effect of sleepiness does not signify overdosage, though.
Learn more about Oxybutynin here:
brainly.com/question/7495345
#SPJ4
Answer:
D. After listening, the pharmacist could restate the instructions in his own words and then ask if he understood correctly.
Explanation:
I calculated it logically
Answer:
The white blood cells i.e. granulocytes and macrophages are specifically stimulated by GM-CSF in response to chemotherapy in cancer patients.
Explanation:
The colony stimulating factors (CSFs) are the regulators of granulocytes and macrophages in blood. The CSFs has the potential to regenerate the white blood cells damaged during chemotherapy. Thus, CSFs mobilize the stem cells to enhance the immune process and produce hematopoietic cells such as granulocytes, macrophages in cancer patients. The CSFs resemble hormones that are specifically targeted to produce blood cells in specified regions where the quantity of those cells is low. The CSFs belong to a group of regulatory factors also known as cytokines and does not produce only a single cell type but stimulates colonies of different blood cell types for any specific organ. Hematopoietic cells produced by CSF are step-wise and formation of blast colonies take place initially. Afterwards, the blast cells regenerate and differentiated into multiple progenitor cells consisting of granulocytes, monocytes, macrophages, eosinophills, erythroids, and lymphocytes. The progenitor cells in the granulocyte-macrophage lineage matures into neutrophilic granulocytes and macrophages.
Out of all types of CSF colonies, the Granulocyte-Macrophage (GM-CSF) colony is specially involved in regenerating immune responses in cancer patients. These cytokines stimulates the dendritic cell formation and produces dendritic activity against the cancerous cells. These GM-CSF colonies enhance the immune response of host against melanomas, tumors by reducing their growth and inducing remission. Hence, it can be said that granulocytes and macrophages are infection protective cells and elevates dangerously low levels of white blood cells in cancer patients following chemotherapy. The GM-CSF induction regenerates the bone marrow which is damaged and improves stem cells production.
